Terms: = Uterine cancer AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Treatment
27 results:
1. Vitexin suppresses the proliferation, angiogenesis and stemness of endometrial cancer through the PI3K/AKT pathway.
Liang C; Jiang Y; Sun L
Pharm Biol; 2023 Dec; 61(1):581-589. PubMed ID: 36994813
[TBL] [Abstract] [Full Text] [Related]
2. Knockdown of CENPU inhibits cervical cancer cell migration and stemness through the FOXM1/Wnt/β-catenin pathway.
Zhang X; Wang M; Zhang Y; Yang J; Duan W
Tissue Cell; 2023 Apr; 81():102009. PubMed ID: 36608638
[TBL] [Abstract] [Full Text] [Related]
3. Mouse uterine stem cells are affected by endocrine disruption and initiate uteropathies.
Singh P; Bhartiya D
Reproduction; 2023 Mar; 165(3):249-268. PubMed ID: 36488194
[TBL] [Abstract] [Full Text] [Related]
4. Metformin in Combination with Progesterone Improves the Pregnancy Rate for Patients with Early Endometrial cancer.
Yuan F; Hu Y; Han X; Li Q
Contrast Media Mol Imaging; 2022; 2022():1961016. PubMed ID: 35854762
[No Abstract] [Full Text] [Related]
5. ALDH1 & CD133 in invasive cervical carcinoma & their association with the outcome of chemoradiation therapy.
Javed S; Sood S; Rai B; Bhattacharyya S; Bagga R; Srinivasan R
Indian J Med Res; 2021 Aug; 154(2):367-374. PubMed ID: 35295009
[TBL] [Abstract] [Full Text] [Related]
6. MACC1 regulates the AKT/STAT3 signaling pathway to induce migration, invasion, cancer stemness, and suppress apoptosis in cervical cancer cells.
Mei J; Zhu C; Pan L; Li M
Bioengineered; 2022 Jan; 13(1):61-70. PubMed ID: 34939526
[TBL] [Abstract] [Full Text] [Related]
7. The IVF-generated human embryonic microenvironment reverses progestin resistance in endometrial cancer cells by inducing cancer stem cell differentiation.
Sun D; Qin Z; Xu Y; Xiao Q; Xu Y; Bai M; Li W; Liu Y; Zheng W; Zhang Z
Cancer Lett; 2022 Feb; 526():311-321. PubMed ID: 34775003
[TBL] [Abstract] [Full Text] [Related]
8. LncRNA AFAP1-AS1/miR-27b-3p/VEGF-C axis modulates stemness characteristics in cervical cancer cells.
Xia M; Duan LJ; Lu BN; Pang YZ; Pang ZR
Chin Med J (Engl); 2021 Jul; 134(17):2091-2101. PubMed ID: 34334630
[TBL] [Abstract] [Full Text] [Related]
9. A synergy of estradiol with leptin modulates the long non-coding RNA NEAT1/ mmu-miR-204-5p/IGF1 axis in the uterus of high-fat-diet-induced obese ovariectomized mice.
Shetty A; Suresh PS
J Steroid Biochem Mol Biol; 2021 May; 209():105843. PubMed ID: 33588025
[TBL] [Abstract] [Full Text] [Related]
10. α-Mangostin attenuates stemness and enhances cisplatin-induced cell death in cervical cancer stem-like cells through induction of mitochondrial-mediated apoptosis.
Chien HJ; Ying TH; Hsieh SC; Lin CL; Yu YL; Kao SH; Hsieh YH
J Cell Physiol; 2020 Jul; 235(7-8):5590-5601. PubMed ID: 31960449
[TBL] [Abstract] [Full Text] [Related]
11. Nanoquinacrine sensitizes 5-FU-resistant cervical cancer stem-like cells by down-regulating Nectin-4 via ADAM-17 mediated NOTCH deregulation.
Nayak A; Das S; Nayak D; Sethy C; Narayan S; Kundu CN
Cell Oncol (Dordr); 2019 Apr; 42(2):157-171. PubMed ID: 30603978
[TBL] [Abstract] [Full Text] [Related]
12. Silencing Bmi1 expression suppresses cancer stemness and enhances chemosensitivity in endometrial cancer cells.
Kim M; Lee S; Park WH; Suh DH; Kim K; Kim YB; No JH
Biomed Pharmacother; 2018 Dec; 108():584-589. PubMed ID: 30243092
[TBL] [Abstract] [Full Text] [Related]
13. Evaluating a community-based cervical cancer screening strategy in Western Kenya: a descriptive study.
Swanson M; Ibrahim S; Blat C; Oketch S; Olwanda E; Maloba M; Huchko MJ
BMC Womens Health; 2018 Jul; 18(1):116. PubMed ID: 29970063
[TBL] [Abstract] [Full Text] [Related]
14. Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the oct4-miR-18a pathway in cervical cancer.
Dong P; Xiong Y; Yu J; Chen L; Tao T; Yi S; Hanley SJB; Yue J; Watari H; Sakuragi N
Oncogene; 2018 Sep; 37(39):5257-5268. PubMed ID: 29855617
[TBL] [Abstract] [Full Text] [Related]
15. CD44+/CD24+ cervical cancer cells resist radiotherapy and exhibit properties of cancer stem cells.
Liu H; Wang YJ; Bian L; Fang ZH; Zhang QY; Cheng JX
Eur Rev Med Pharmacol Sci; 2016 May; 20(9):1745-54. PubMed ID: 27212166
[TBL] [Abstract] [Full Text] [Related]
16. Doxycycline Induces Apoptosis and Inhibits Proliferation and Invasion of Human Cervical Carcinoma Stem Cells.
Yang B; Lu Y; Zhang A; Zhou A; Zhang L; Zhang L; Gao L; Zang Y; Tang X; Sun L
PLoS One; 2015; 10(6):e0129138. PubMed ID: 26111245
[TBL] [Abstract] [Full Text] [Related]
17. Stro-1/CD44 as putative human myometrial and fibroid stem cell markers.
Mas A; Nair S; Laknaur A; Simón C; Diamond MP; Al-Hendy A
Fertil Steril; 2015 Jul; 104(1):225-34.e3. PubMed ID: 25989979
[TBL] [Abstract] [Full Text] [Related]
18. Imiquimod treatment effectively reduces the percentage of viable cells in a cervical carcinoma cell line but does not affect the expression of HLA-G or OCT-4.
Stefanidis K; Patta J; Pergialiotis V; Stefanidi D; Loutradis D
J Stem Cells; 2015; 10(4):217-23. PubMed ID: 27144826
[TBL] [Abstract] [Full Text] [Related]
19. High Expression of SOX2 and oct4 Indicates Radiation Resistance and an Independent Negative Prognosis in Cervical Squamous Cell Carcinoma.
Shen L; Huang X; Xie X; Su J; Yuan J; Chen X
J Histochem Cytochem; 2014 Jul; 62(7):499-509. PubMed ID: 24710660
[TBL] [Abstract] [Full Text] [Related]
20. Clinical significance of the stem cell gene Oct-4 in cervical cancer.
Yang Y; Wang Y; Yin C; Li X
Tumour Biol; 2014 Jun; 35(6):5339-45. PubMed ID: 24532469
[TBL] [Abstract] [Full Text] [Related]
[Next]
